Your browser doesn't support javascript.
loading
Absorption, metabolism, and excretion of [14C]YY-20394, a highly selective PI3K-Delta inhibitor in humans.
Yu, Jinghua; Zhang, Hua; Zhang, Yifan; Zhan, Yan; Ma, Sheng; Hu, Tao; Zhang, Ning; Lou, Yangtong; Bao, Hanying; Xu, Zusheng; Zhong, Dafang; Miao, Liyan; Diao, Xingxing.
Afiliação
  • Yu J; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Zhang H; Department of Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang Y; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, China.
  • Zhan Y; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Ma S; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Hu T; Department of Pharmacology, the First Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang N; Institute for Interdisciplinary Drug Research and Translational Sciences, Soochow University, Suzhou, China.
  • Lou Y; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Bao H; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Xu Z; Shanghai Yingli Pharmaceutical Co., Ltd, Shanghai, China.
  • Zhong D; Shanghai Yingli Pharmaceutical Co., Ltd, Shanghai, China.
  • Miao L; Shanghai Yingli Pharmaceutical Co., Ltd, Shanghai, China.
  • Diao X; Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Xenobiotica ; 52(3): 254-264, 2022 Mar.
Article em En | MEDLINE | ID: mdl-35373704

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Xenobiotica Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Inibidores de Proteínas Quinases Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Revista: Xenobiotica Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China